METASTATIC MUCOSAL MELANOMA
Clinical trials for METASTATIC MUCOSAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MUCOSAL MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Custom-Made vaccine targets tough cancers in early trial
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase study is testing a personalized vaccine made from each patient's unique tumor mutations. The goal is to see if it is safe and can help the immune system fight advanced breast cancer, melanoma, and non-small cell lung cancer. About 25 adults whose cancers have spr…
Matched conditions: METASTATIC MUCOSAL MELANOMA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 18, 2026 12:04 UTC
-
Morning may matter: new trial tests timing of immunotherapy for melanoma
Disease control Recruiting nowThis study is for people with advanced melanoma that has spread or cannot be removed by surgery. It tests whether giving two immunotherapy drugs (ipilimumab and nivolumab) in the morning works better than giving them later in the day. The goal is to see if timing can improve how …
Matched conditions: METASTATIC MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 07:59 UTC
-
New combo aims to shrink brain tumors in advanced melanoma
Disease control Recruiting nowThis study tests whether a combination of targeted drugs (encorafenib and binimetinib) plus an immunotherapy (nivolumab) works better than two immunotherapies (ipilimumab and nivolumab) for people with BRAF-V600 mutant melanoma that has spread to the brain. About 112 adults with …
Matched conditions: METASTATIC MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Spinal immunotherapy injection shows promise for tough brain cancers
Disease control Recruiting nowThis early-phase study tests a combination of two ways to give the immunotherapy drug nivolumab: through a vein and directly into the fluid around the spine. It is for people with melanoma or lung cancer that has spread to the lining of the brain or spinal cord (leptomeningeal di…
Matched conditions: METASTATIC MUCOSAL MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC